Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912452927> ?p ?o ?g. }
- W2912452927 abstract "Since 2011 six immune checkpoint inhibitors (ICI) have been approved to treat patients with many advanced solid tumor and hematological malignancies to improve their prognosis. Case reports of their endocrine immune-related adverse events [irAEs]) are increasingly published as more real-world patients with these malignancies are treated with these drugs. They alert physicians of a drug’s AEs (which may change during a drug’s life cycle) and contribute to post-marketing safety surveillance. Using a modified framework of Arksey and O’Malley, we conducted a scoping review of the spectrum and characteristics of ICI-induced endocrinopathies case reports before and after ICIs are marketed. In July 2017, we searched, without date and language restrictions, 4 citation databases for ICI-induced endocrinopathies. We also hand-searched articles’ references, contents of relevant journals, and ran supplemental searches to capture recent reports through January 2018. For this study, a case should have information on type of cancer, type of ICI, clinical presentation, biochemical tests, treatment plus temporal association of ICI initiation with endocrinopathies. Two endocrinologists independently extracted the data which were then summarized and categorized. One hundred seventy nine articles reported 451 cases of ICI-induced endocrinopathies - 222 hypopituitarism, 152 thyroid disorders, 66 diabetes mellitus, 6 primary adrenal insufficiencies, 1 ACTH-dependent Cushing’s syndrome, 1 hypoparathyroidism and 3 diabetes insipidus cases. Their clinical presentations reflect hormone excess or deficiency. Some were asymptomatic and others life-threatening. One or more endocrine glands could be affected. Polyglandular endocrinopathies could present simultaneously or in sequence. Many occur within 5 months of therapy initiation; a few occurred after ICI was stopped. Mostly irreversible, they required long-term hormone replacement. High dose steroids were used when non-endocrine AEs coexisted or as therapy in adrenal insufficiency. There was variability of information in the case reports but all met the study criteria to make a diagnosis. The spectrum of ICI-induced endocrinopathies is wide (5 glands affected) and their presentation varied (12 endocrinopathies). Clinical reasoning integrating clinical, biochemical and treatment information is needed to properly diagnose and manage them. Physicians should be vigilant for their occurrence and be able to diagnose, investigate and manage them appropriately at onset and follow-up." @default.
- W2912452927 created "2019-02-21" @default.
- W2912452927 creator A5012494640 @default.
- W2912452927 creator A5015315116 @default.
- W2912452927 creator A5016547950 @default.
- W2912452927 creator A5021290731 @default.
- W2912452927 creator A5021595416 @default.
- W2912452927 creator A5046082287 @default.
- W2912452927 creator A5077829479 @default.
- W2912452927 creator A5086398920 @default.
- W2912452927 date "2019-01-22" @default.
- W2912452927 modified "2023-10-18" @default.
- W2912452927 title "Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports" @default.
- W2912452927 cites W129435290 @default.
- W2912452927 cites W1494696914 @default.
- W2912452927 cites W1523370243 @default.
- W2912452927 cites W1625861559 @default.
- W2912452927 cites W1725918626 @default.
- W2912452927 cites W1767743048 @default.
- W2912452927 cites W1966431971 @default.
- W2912452927 cites W1969965329 @default.
- W2912452927 cites W1985110807 @default.
- W2912452927 cites W1986659781 @default.
- W2912452927 cites W1987234856 @default.
- W2912452927 cites W1987583599 @default.
- W2912452927 cites W1988822265 @default.
- W2912452927 cites W1999935292 @default.
- W2912452927 cites W2008497077 @default.
- W2912452927 cites W2011991703 @default.
- W2912452927 cites W2017347750 @default.
- W2912452927 cites W2032060513 @default.
- W2912452927 cites W2036109307 @default.
- W2912452927 cites W2036195858 @default.
- W2912452927 cites W2037226944 @default.
- W2912452927 cites W2047185812 @default.
- W2912452927 cites W2048296690 @default.
- W2912452927 cites W2056085563 @default.
- W2912452927 cites W2068946981 @default.
- W2912452927 cites W2070114596 @default.
- W2912452927 cites W2075950485 @default.
- W2912452927 cites W2079713973 @default.
- W2912452927 cites W2084154288 @default.
- W2912452927 cites W2085247907 @default.
- W2912452927 cites W2085477313 @default.
- W2912452927 cites W2085567820 @default.
- W2912452927 cites W2086311038 @default.
- W2912452927 cites W2095327463 @default.
- W2912452927 cites W2096060394 @default.
- W2912452927 cites W2100127605 @default.
- W2912452927 cites W2103741075 @default.
- W2912452927 cites W2104430075 @default.
- W2912452927 cites W2110773108 @default.
- W2912452927 cites W2113287405 @default.
- W2912452927 cites W2119218381 @default.
- W2912452927 cites W2123355918 @default.
- W2912452927 cites W2124178836 @default.
- W2912452927 cites W2127446775 @default.
- W2912452927 cites W2130075738 @default.
- W2912452927 cites W2130826590 @default.
- W2912452927 cites W2134638467 @default.
- W2912452927 cites W2137631342 @default.
- W2912452927 cites W2152904965 @default.
- W2912452927 cites W2153329308 @default.
- W2912452927 cites W2166107256 @default.
- W2912452927 cites W2169351454 @default.
- W2912452927 cites W2179179825 @default.
- W2912452927 cites W2180714450 @default.
- W2912452927 cites W2193279488 @default.
- W2912452927 cites W2209326243 @default.
- W2912452927 cites W2216290707 @default.
- W2912452927 cites W2237934598 @default.
- W2912452927 cites W2253549412 @default.
- W2912452927 cites W2278440281 @default.
- W2912452927 cites W2287163376 @default.
- W2912452927 cites W2310054409 @default.
- W2912452927 cites W2312652471 @default.
- W2912452927 cites W2312817377 @default.
- W2912452927 cites W2323492293 @default.
- W2912452927 cites W2336279251 @default.
- W2912452927 cites W2338994579 @default.
- W2912452927 cites W2340628808 @default.
- W2912452927 cites W2368502720 @default.
- W2912452927 cites W2409477261 @default.
- W2912452927 cites W2412289429 @default.
- W2912452927 cites W2438354826 @default.
- W2912452927 cites W2467060254 @default.
- W2912452927 cites W2468424132 @default.
- W2912452927 cites W2473188914 @default.
- W2912452927 cites W2487303921 @default.
- W2912452927 cites W2488216319 @default.
- W2912452927 cites W2501357434 @default.
- W2912452927 cites W2504137880 @default.
- W2912452927 cites W2508019031 @default.
- W2912452927 cites W2514996986 @default.
- W2912452927 cites W2523986803 @default.
- W2912452927 cites W2524128494 @default.
- W2912452927 cites W2530468309 @default.
- W2912452927 cites W2532961791 @default.
- W2912452927 cites W2533633657 @default.
- W2912452927 cites W2534016730 @default.